BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 190261)

  • 1. Characteristics of high molecular weight insulins in insulinoma patients.
    Permutt M; Biesbroeck J; Chyn R
    J Clin Endocrinol Metab; 1977 Mar; 44(3):536-44. PubMed ID: 190261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-molecular IRI (big, big insulin) in islet cell adenoma.
    Melani F; Beischer W; Keller L; Pfeiffer EF
    Horm Metab Res; 1976; Suppl 6():63-6. PubMed ID: 179931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma proinsulin-like components.
    Gorden P; Roth J; Hendricks CM; Kahn CR
    Isr J Med Sci; 1974 Oct; 10(10):1212-21. PubMed ID: 4373413
    [No Abstract]   [Full Text] [Related]  

  • 4. Human insulinoma tissue: in vitro studies of proinsulin/insulin biosynthesis and release.
    Track NS; Creutzfeldt C; Creutzfeldt W
    Horm Metab Res; 1976; Suppl 6():19-25. PubMed ID: 179925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered glucose regulation of insulin biosynthesis in insulinoma cells: mouse beta TC3 cells secrete insulin-related peptides predominantly via a constitutive pathway.
    Nagamatsu S; Steiner DF
    Endocrinology; 1992 Feb; 130(2):748-54. PubMed ID: 1733723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and pancreatic immunoreactive insulin (IRI) and proinsulin-like component (PLC), serum IRI and PLC response to different stimuli in normal subjects and organic hyperinsulinism.
    Rastogi GK; Sialy R; Sinha MK; Dash R; Chopra JS; Kataria RN
    Acta Diabetol Lat; 1975; 12(5-6):309-23. PubMed ID: 181932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation during storage of high molecular weight immunoreactive insulin (HWIRI) and proinsulin (PLC) in extracts of Benign insulinomas and adjacent pancreatic tissue.
    Villaume C; Beck B; Pointel JP; Drouin P; Debry G
    Horm Metab Res; 1981 Sep; 13(9):528-9. PubMed ID: 6271661
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolism of insulin and immunoreactive insulin-like substances (proinsulin, HWIRI) in vivo in man].
    Villaume C; Beck B; Pointel JP; Drouin P; Debry G
    Ann Endocrinol (Paris); 1982; 43(1):15-21. PubMed ID: 6291446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal, hepatic and peripheral insulin immunoreactive substances before and after removal of an insulinoma.
    Villaume C; Beck B; Pointel JP; Drouin P; Debry G
    J Endocrinol Invest; 1982; 5(5):315-21. PubMed ID: 6296220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatographic heterogeneity of insulin extracted from insulomas.
    Beischer W; Melani F; Keller L; Pfeiffer EF
    J Clin Endocrinol Metab; 1975 Mar; 40(3):393-400. PubMed ID: 234976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulinoma with low circulating insulin levels: the diagnostic value of proinsulin measurements.
    Alsever RN; Roberts JP; Gerber JG; Mako ME; Rubenstein AH
    Ann Intern Med; 1975 Mar; 82(3):347-50. PubMed ID: 163611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of immunoassays for insulin in diagnostic tests for insulinoma.
    Shimizu T; Sasakuma F; Ishikawa O; Matsumiya K; Hasegawa K; Sasaki A
    Diabetes Res Clin Pract; 1994 Dec; 26(2):149-54. PubMed ID: 7705197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free translation of messenger RNA extracted from a human insulinoma.
    Permutt MA; Chyn R; Goldford M; Boime I
    J Clin Endocrinol Metab; 1978 Jun; 46(6):897-901. PubMed ID: 233702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotropin-releasing hormone and insulin in chemically induced pancreatic islet cell tumors in rats.
    Kazumi T; Hirose Y; Ishihara K; Makimura H; Yoshino G; Utsumi M; Baba S
    Horm Metab Res; 1986 Sep; 18(9):584-6. PubMed ID: 3023223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor and serum levels of proinsulin and insulin in insulinoma patients.
    Tasaka Y; Nakaya F; Matsumoto H; Odagiri R; Ohgawara H; Omori Y
    Endocr J; 1993 Apr; 40(2):245-8. PubMed ID: 7951510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of proinsulin-insulin intermediates in human plasma.
    de Haƫn C; Little SA; May JM; Williams RH
    J Clin Invest; 1978 Oct; 62(4):727-37. PubMed ID: 359597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 28-hour profiles of blood glucose (BG), plasma immunoreactive insulin (IRI) and IRI/BG ratio in four insulinomas.
    Villaume C; Beck B; Dollet JM; Pointel JP; Drouin P; Debry G
    Ann Endocrinol (Paris); 1984; 45(3):155-60. PubMed ID: 6098216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The insulin-secretory-granule carboxypeptidase H. Purification and demonstration of involvement in proinsulin processing.
    Davidson HW; Hutton JC
    Biochem J; 1987 Jul; 245(2):575-82. PubMed ID: 2822027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of expression and secretion of native and mutant [AspB10]insulin in AtT20 cells.
    Ferber S; Gross DJ; Villa-Komaroff L; Danehy F; Vollenweider F; Meyer K; Loeken MR; Kahn CR; Halban PA
    Mol Endocrinol; 1991 Mar; 5(3):319-26. PubMed ID: 1890988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthesis of proinsulin and insulin in newborn rat pancreas. Interaction of glucose, cyclic AMP, somatostatin, and sulfonylureas on the (3H) leucine incorporation into immunoreactive insulin.
    Garcia SD; Jarrousse C; Rosselin G
    J Clin Invest; 1976 Jan; 57(1):230-43. PubMed ID: 173741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.